Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate

Journal of Virology

Volumn 75, Issue 16, 2001, Pages 7517-7527

  Wang, F Z ^a   Akula, S M ^a   Pramod, N P ^a   Zeng, L ^a   Chandran, B ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; ENVELOPE PROTEIN; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; HEPARIN DERIVATIVE; THYMIDINE; TRITIUM;

ANIMAL CELL; ARTICLE; BACULOVIRUS; CELL INTERACTION; CHO CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; TARGET CELL;

ANIMALS; CHO CELLS; CRICETINAE; GLYCOPROTEINS; HEPARITIN SULFATE; HERPESVIRUS 8, HUMAN; HUMANS; PROTEIN BINDING; RECEPTORS, VIRUS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0034902748     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.16.7517-7527.2001     Document Type: Article

References (61)

1. Primary structure of the herpesvirus saimiri genome
2. Human herpesvirus 8 (HHV-8/KSHV) infection of target cells involves interaction with heparan sulfate
3. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen
4. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8
5. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells
6. Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B
7. Binding of Sindbis virus to cell surface heparan sulfate
8. Molecular modeling of protein-glycosaminoglycan interactions
9. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences
10. Human herpesvirus-8 ORF K8.1 gene encodes immunogenic glycoproteins generated by spliced transcripts
11. Identification and characterization of human herpesvirus-8 lytic cycle associated ORF 59 protein and the encoding cDNA by monoclonal antibody
12. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
13. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay
14. A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate
15. The Kaposi's sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients
16. Human herpesvirus 8 in the prostate glands of men with Kaposi's sarcoma
17. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma
18. Animal cell mutants defective in glycosaminoglycan biosynthesis
19. The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate
20. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus
21. The receptor-binding domain of pseudorabies virus glycoprotein gC is composed of multiple discrete units that are functionally redundant
22. Intracellular trafficking of two major Epstein-Barr virus glycoproteins, gp350/220 and gp110
23. Virus receptors: Binding, adhesion strengthening, and changes in viral structure
24. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B
25. Modification of Epstein-Barr virus replication by tunicamycin
26. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate
27. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission
28. Proteoglycans: Structures and interactions
29. Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells
30. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread
31. Mapping of heparin-binding structures on bovine herpesvirus 1 and pseudorabies virus gIII glycoproteins
32. A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis
33. Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus
34. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8
35. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells
36. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: Determinants of its pathogenicity?
37. Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate
38. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines
39. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells
40. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture
41. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41
42. Microbial adherence to and invasion through proteoglycans
43. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
44. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8)
45. Role of the extracellular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycans
46. Herpesvirus-induced cell fusion that is dependent on cell surface heparan sulfate or soluble heparin
47. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry
48. High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells
49. Identification and analysis of a novel heparin-binding glycoprotein encoded by human herpesvirus 7
50. Detection of human herpesvirus 8 DNA in Kaposi's sarcoma lesions and peripheral blood of human immunodeficiency virus-positive patients and correlation with serologic measurements
51. Entry of alphaherpesviruses into cells
52. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells
53. Identification and characterization of murine gammaherpesvirus 68 gp150: A virion membrane glycoprotein
54. Heparan sulphate
55. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
56. Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity
57. Attachment of the gammaherpesvirus bovine herpesvirus 4 is mediated by the interaction of gp8 glycoprotein with heparinlike moieties on the cell surface
58. Activation of Kaposi's sarcoma-associated herpesvirus (HHV8) lytic replication by human cytomegalovirus
59. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate
60. Characterization of human herpesvirus-8 8-K8.1A/B glycoproteins by monoclonal antibodies
61. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8 infected BCBL-1 cells